{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:18:04Z","timestamp":1773094684699,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.4065\/75.4.386","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:17:28Z","timestamp":1232759848000},"page":"386-394","source":"Crossref","is-referenced-by-count":43,"title":["Treatment Guidelines for HIV-Associated Wasting"],"prefix":"10.4065","volume":"75","author":[{"given":"Patrick M.","family":"Nemechek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Polsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.4065\/75.4.386_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000227129","article-title":"HIV-related cachexia: potential mechanisms and treatment","volume":"49","author":"Von Roenn","year":"1992","journal-title":"Oncology"},{"key":"10.4065\/75.4.386_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ajcn\/50.3.444","article-title":"Magnitude of body-eell-mass depletion and the timing of death from wasting in AIDS","volume":"50","author":"Kotler","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"10.4065\/75.4.386_bib3","first-page":"595","article-title":"Treatment for HIV wasting syndrome","volume":"28","author":"Cat","year":"1994","journal-title":"Ann Pharmacother"},{"issue":"suppl L","key":"10.4065\/75.4.386_bib4","first-page":"1S","article-title":"Council of State and Territorial Epidemiologists, AIDS Program, Center for Infectious Diseases. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome","volume":"36","year":"1987","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.4065\/75.4.386_bib5","unstructured":"Wheeler DA, Muurahainen N, Elion R, Launer C, Gibert C, Bartsch G. Change in body weight (WT) as a predictor of death and opportunistic complications (OC) in HIV by history of prior OC. In: Program and abstracts of the XI International Conference on AIDS; July 7\u201312, 19%; Vancouver, British Columbia. Abstract Tu.B.2383."},{"key":"10.4065\/75.4.386_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.1963.tb17072.x","article-title":"Body cell mass and limits of hydration of the fat-free body: their relation to estimated skeletal weight","volume":"110","author":"Moore","year":"1963","journal-title":"Ann AM YAcad Sci"},{"key":"10.4065\/75.4.386_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0148607193017005401","article-title":"Bioelectrical impedance analysis: a way to assess changes in body eell mass in patients with acquired immunodeficiency syndrome? [editorial]","volume":"17","author":"Jacobs","year":"1993","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.4065\/75.4.386_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ajcn\/56.1.19","article-title":"The five-level model: a new approach to organizing body-composition research","volume":"56","author":"Wang","year":"1992","journal-title":"Am. J Clin Nutr"},{"key":"10.4065\/75.4.386_bib9","first-page":"1288","article-title":"Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS","volume":"84","author":"Chlebowski","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/75.4.386_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00042560-199511000-00009","article-title":"Multicenter AIDS Cohort Study Investigators. Weight loss prior to clinical AIDS as a predictor of survival","volume":"10","author":"Palenicek","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.4065\/75.4.386_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0025-7125(16)30225-5","article-title":"Malnutrition in AIDS","volume":"77","author":"Keusch","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.4065\/75.4.386_bib12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.1994.10.931","article-title":"Wasting syndrome: nutritional support in HIV infection","volume":"10","author":"Kotler","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.4065\/75.4.386_bib13","first-page":"229","article-title":"Palhophysiology and treatment of the AIDS wasting syndrome","author":"Kotler","year":"1995","journal-title":"AIDS Clin Rev"},{"key":"10.4065\/75.4.386_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0899-9007(97)82628-7","article-title":"Variation in body weight and plasma viral load in HIV patients treated with tri therapy including a protease inhibitor [abstract]","volume":"13","author":"Teixeira","year":"1997","journal-title":"Nutrition"},{"key":"10.4065\/75.4.386_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0899-9007(97)82701-3","article-title":"Correlation between body composition, caloric intake and plasma viral load in HIV infected patients [abstract]","volume":"13","author":"Zucman","year":"1997","journal-title":"Nutrition"},{"key":"10.4065\/75.4.386_bib16","unstructured":"Berger D, Cimoch P, Nemechek P, et al. Measurement of body weight and body cell mass in patients receiving highly active anliretroviral therapy (HAART). In: Program and abstracts of the 37th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28-Oclober 1, 1997; Toronto, Ontario."},{"key":"10.4065\/75.4.386_bib17","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","article-title":"lndinavir-associated lipodystrophy","volume":"12","author":"Viraben","year":"1998","journal-title":"AIDS"},{"key":"10.4065\/75.4.386_bib18","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.4065\/75.4.386_bib19","unstructured":"Torres RA, Treatment of dorsocervtcal fat pads and truncal adiposity with Serostim (recombinant human growth hormone) in patients with AIDS maintained on HAART. In: Program and abstracts of the 12th World AIDS Conference; June 28-July 3, 1998; Geneva, Switzerland. Abstract 32164."},{"key":"10.4065\/75.4.386_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042560-199702010-00004","article-title":"Longitudinal changes in body composition measured with a variety of methods in patients with AIDS","volume":"14","author":"Paton","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirot"},{"key":"10.4065\/75.4.386_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00042560-199505010-00003","article-title":"Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection","volume":"9","author":"Ott","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"suppl","key":"10.4065\/75.4.386_bib22","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1093\/ajcn\/64.3.489S","article-title":"Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease","volume":"64","author":"Kotler","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.4065\/75.4.386_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00042560-199705010-00007","article-title":"Cross-sectional and longitudinal evaluation of body composition in men with HIV infection","volume":"15","author":"Mulligan","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirot"},{"key":"10.4065\/75.4.386_bib24","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1210\/jc.82.5.1332","article-title":"Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting [published correction appears in J Clin Endocrinol Melab. 1997;82:3360]","volume":"82","author":"Grinspoon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/75.4.386_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00004045-199501000-00009","article-title":"AIDS and malnutrition: dual assaults on the body","volume":"13","author":"Merrill","year":"1995","journal-title":"Home Healthc Nurse"},{"key":"10.4065\/75.4.386_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0193-953X(18)30136-9","article-title":"Psychological impact of HIV disease and implications for intervention","volume":"17","author":"Chesney","year":"1994","journal-title":"Psychiatr Clin North Am"},{"key":"10.4065\/75.4.386_bib27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1176\/ajp.146.6.737","article-title":"HIV-relaled symptoms and psychological functioning in a cohort of homosexual men","volume":"146","author":"Ostrow","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.4065\/75.4.386_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0891-5520(20)30603-6","article-title":"Nutritional aspects of HIV infection","volume":"8","author":"Nerad","year":"1994","journal-title":"Infect Dis Clin North Am"},{"key":"10.4065\/75.4.386_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1055-3290(97)80047-7","article-title":"Malnutrition associated with HIV\/AIDS, part one: definition and scope, epidemiology, and palhophysiology [published correction appears in J Assoc Nurses AIDS Care. 1998;9:861","volume":"8","author":"Casey","year":"1997","journal-title":"JAssoe Nurses AIDS Care"},{"key":"10.4065\/75.4.386_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0140-6736(95)92229-6","article-title":"HIV-associaled diairhoea and wasting","volume":"346","author":"DuPont","year":"1995","journal-title":"Lancet"},{"key":"10.4065\/75.4.386_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-101-4-421","article-title":"Enteropathy associated with the acquired immunodeficiency syndrome","volume":"101","author":"Kotler","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.4065\/75.4.386_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0035-9203(92)90323-5","article-title":"The slim disease in African patients with AIDS","volume":"86","author":"Mhiri","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.4065\/75.4.386_bib33","first-page":"46","article-title":"Endocrine function in the HIV wasting syndrome","volume":"7","author":"Coodley","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.4065\/75.4.386_bib34","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1210\/jc.81.11.4051","article-title":"Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/75.4.386_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00002030-199106000-00013","article-title":"Endocrine function in 98 HIV-infected patients: a prospective study","volume":"5","author":"Raffi","year":"1991","journal-title":"AIDS"},{"key":"10.4065\/75.4.386_bib36","unstructured":"Severson K, Nemechek P. Free testosterone as a predictor for body composition changes in males with HIV or AIDS. In: Program and abstracts of the XI International Conference on AIDS; July 7\u201312, 1996; Vancouver, British Columbia. Abstract Tu.B.2385."},{"key":"10.4065\/75.4.386_bib37","unstructured":"Berger D, Muurahainen N. Wittert H, Bucher G, Baker BE, Baiser JP. Hypogonadism and wasting in the era of HAART in HIV-infected patients. In: Program and abstracts of the 12th World AIDS Conference, June 28-July 3, 1998; Geneva, Switzerland. Abstract 32174."},{"key":"10.4065\/75.4.386_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/edrv-14-1-20","article-title":"Human growth hormone and human aging","volume":"14","author":"Corpas","year":"1993","journal-title":"Endocr Rev"},{"key":"10.4065\/75.4.386_bib39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3181\/00379727-212-44021A","article-title":"Catabolic hormones and growth hormone resistance in acquired immunodeficiency syndrome and other catabolic states","volume":"212","author":"Rodgers","year":"1996","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.4065\/75.4.386_bib40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1210\/jc.77.4.956","article-title":"Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection","volume":"77","author":"Mulligan","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/75.4.386_bib41","first-page":"245","article-title":"Anthropometrie, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex","volume":"6","author":"Krenlz","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.4065\/75.4.386_bib42","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1210\/jc.81.11.4028","article-title":"Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome","volume":"81","author":"Heijligenberg","year":"1996","journal-title":"Clin Endocrinol Metab"},{"key":"10.4065\/75.4.386_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM199207303270506","article-title":"Metabolic disturbances and wasting in the acquired immunodeficiency syndrome","volume":"327","author":"Grunfeld","year":"1992","journal-title":"N Engt J Med"},{"key":"10.4065\/75.4.386_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ajcn\/54.2.311","article-title":"Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HlV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage","volume":"54","author":"Hommes","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.4065\/75.4.386_bib45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/jc.76.3.559","article-title":"Increased de novo hepatic lipogenesis in human immunodeficiency virus infection","volume":"76","author":"Hellerstein","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/75.4.386_bib46","first-page":"EI77","article-title":"Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production","volume":"259","author":"Feingold","year":"1990","journal-title":"Am J Physiol"},{"key":"10.4065\/75.4.386_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ajcn\/53.1.149","article-title":"Enterai alimentation and repletion of body cell mass in malnourished patients with acquired immunodeficiency syndrome","volume":"53","author":"Kotler","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.4065\/75.4.386_bib48","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/0148607190014005454","article-title":"Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome","volume":"14","author":"Kotler","year":"1990","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.4065\/75.4.386_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcn\/51.1.7","article-title":"Preservation of short-term energy balance in clinically stable patients with AIDS","volume":"51","author":"Kotler","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.4065\/75.4.386_bib50","series-title":"Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases","first-page":"1217","article-title":"Clinical manifestations of HIV infection","author":"Chaisson","year":"1995"},{"key":"10.4065\/75.4.386_bib51","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.272.5265.1124","article-title":"Viral counts count in HIV infection","volume":"272","author":"Ho","year":"1996","journal-title":"Science"},{"key":"10.4065\/75.4.386_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ajcn\/58.3.317","article-title":"Body weight as essential data in the management of patients with human immunodeficiency virus infection and the acquired immunodeficiency syndrome [editorial]","volume":"58","author":"Grunfeld","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.4065\/75.4.386_bib53","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00002030-199309000-00010","article-title":"Clinical risk factors for malnutrition in HIV-1 -infected patients","volume":"7","author":"Schwenk","year":"1993","journal-title":"AIDS"},{"key":"10.4065\/75.4.386_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajcn\/57.1.15","article-title":"Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition","volume":"57","author":"Ott","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.4065\/75.4.386_bib55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0899-9007(97)82694-9","article-title":"Characteristics of change in body composition with efficiency of antiretroviral treatment in AIDS patients [abstract]","volume":"13","author":"Force","year":"1997","journal-title":"Nutrition"},{"key":"10.4065\/75.4.386_bib56","series-title":"A Biometrie Study of Basal Metabolism in Man","first-page":"223","author":"Harris","year":"1919"},{"key":"10.4065\/75.4.386_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-116-2-129","article-title":"Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument","volume":"116","author":"Wachtel","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/75.4.386_bib58","first-page":"1050","article-title":"Functional status of persons with HIV infection in an ambulatory setting","volume":"7","author":"Stanton","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.4065\/75.4.386_bib59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.1989.00390040105021","article-title":"Body mass repletion during ganciclovir treatment of cylomegalovirus infections in patients with acquired immunodeficiency syndrome","volume":"149","author":"Kotler","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.4065\/75.4.386_bib60","doi-asserted-by":"crossref","unstructured":"Abbaticola M. Fisher A. Effects of recombinant human growth hormone (r-hGH) and aggressive nutrition support (NS) on body weight (BW) in HIV infection and concurrent opportunistic infection (OI). Abstract presented at: Fourth International Conference on Nutrition and HIV Infection; April 22\u201326,1997; Cannes, France.","DOI":"10.1016\/S0899-9007(97)82700-1"},{"key":"10.4065\/75.4.386_bib61","unstructured":"Muurahainen N, Collins G, Wheeler D, Bartsch G, Gibert C. Nutritional status and intake of HIV-infected men in 1996\u20131997. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 1\u20135. 1998; Chicago, 111. Abstract 473."},{"key":"10.4065\/75.4.386_bib62","unstructured":"Kotler DP, Tierney AR, Muurahainen N, Glesby M, Mendez D. Nutritional supplements containing long- or medium-chain triglycerides: effects upon body weight and composition in HIV-infected subjects with <100 CD4+ lymphocytes\/mm3. In: Program and abstracts of the 12th World AIDS Conference; June 28-July 3, 1998; Geneva, Switzerland. Abstract 42347."},{"key":"10.4065\/75.4.386_bib63","first-page":"281A","article-title":"Effects of megestrol acetate therapy upon body composition and serum testosterone in patients with AIDS [abstract]","volume":"42","author":"Engelson","year":"1994","journal-title":"Clin Res"},{"key":"10.4065\/75.4.386_bib64","unstructured":"Kotler D, Shevitz A, Fenton M. Update on wasting, metabolism and altered body shape in HIV\/AIDS. Presented at: satellite meeting of 12th World AIDS Conference; June 28-July 3, 1998; Geneva, Switzerland."},{"key":"10.4065\/75.4.386_bib65","first-page":"16","article-title":"Inadequate dietary intake and altered nutrition status in early HIV-1 infection","volume":"10","author":"Baum","year":"1994","journal-title":"Nutrition"},{"key":"10.4065\/75.4.386_bib66","unstructured":"Mora Rodriguez G. Feregrino-Goyos M, Gomez-Caro WH, Eid-Lidt G, Alvarado-Diez R, Gallegos-Perez H. When why and whom enteral nutritional support (ENS) in AIDS wasting syndrome of AIDS and in the early HIV disease. In: Program and abstracts of the XI International Conference on AIDS; July 7\u201312,1996; Vancouver, British Columbia. Abstract Tu.B.2246."},{"key":"10.4065\/75.4.386_bib67","unstructured":"Nemechek PM, Stolifer 1. A retrospective study on the effect of smoking on total body weight (TBW) and body cell mass (BCM). In: Program and abstracts of the 12th World AIDS Conference; June 28-July 3, 1998; Geneva, Switzerland. Abstract 42340."},{"key":"10.4065\/75.4.386_bib68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.4065\/75.4.386_bib69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/aid.1997.13.305","article-title":"The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome","volume":"13","author":"Tirnpone","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.4065\/75.4.386_bib70","first-page":"1107","article-title":"Effects of megestrol acetate therapy on body composition and circulating testosterone concentrations in patients with AIDS","volume":"9","author":"Engelson","year":"1995","journal-title":"AIDS"},{"key":"10.4065\/75.4.386_bib71","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-109-10-840","article-title":"Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection","volume":"109","author":"Von Rocnn","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4065\/75.4.386_bib72","first-page":"13","article-title":"Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection","volume":"17","author":"Von Roenn","year":"1990","journal-title":"Semin Oncol"},{"key":"10.4065\/75.4.386_bib73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0899-9007(97)82654-8","article-title":"The effects of combination megestrol acetate (MA) and testosterone (T) replacement therapy in AIDS wasting syndrome (AWS) [abstract]","volume":"13","author":"Strawford","year":"1997","journal-title":"Nutrition"},{"key":"10.4065\/75.4.386_bib74","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/095646249200300409","article-title":"Megestrol acetate vs cyproheptadine in the treatment of weight loss associated with HIV infection","volume":"3","author":"Summerbell","year":"1992","journal-title":"Int J STD AIDS"},{"key":"10.4065\/75.4.386_bib75","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/00002030-199612000-00010","article-title":"Oxandrolotte in AIDS-wasting myopathy","volume":"10","author":"Berger","year":"1996","journal-title":"AIDS"},{"key":"10.4065\/75.4.386_bib76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00002030-199606001-00008","article-title":"Safety and efficacy of nandrolone decanoaic for treatment of wasting in patients with HIV infection","volume":"10","author":"Gold","year":"1996","journal-title":"AIDS"},{"key":"10.4065\/75.4.386_bib77","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.281.14.1282","article-title":"Resistance exercise and supraphysioiogic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial","volume":"281","author":"Strawford","year":"1999","journal-title":"JAMA"},{"key":"10.4065\/75.4.386_bib78","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.281.14.1326","article-title":"Is there a role for androgenic anabolic steroids in medical practice?","volume":"281","author":"Dobs","year":"1999","journal-title":"JAMA"},{"key":"10.4065\/75.4.386_bib79","first-page":"129","article-title":"Oxymetholonc promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection","volume":"75","author":"Hengge","year":"1996","journal-title":"BrJNutr"},{"key":"10.4065\/75.4.386_bib80","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00002030-199711000-00008","article-title":"A trial of testosterone therapy for HI V-associaled weight loss","volume":"11","author":"Coodley","year":"1997","journal-title":"AIDS"},{"key":"10.4065\/75.4.386_bib81","unstructured":"Gninfeld G Oxandrolone efficacy in treating wasting. Presented at: 12th World AIDS Conference; July 1, 1998; Geneva, Switzerland."},{"key":"10.4065\/75.4.386_bib82","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/jc.83.8.2717","article-title":"Transdermal testosterone administlraltion in women with aquired immunodeficiency syndrome wasting; a pilot study","volume":"83","author":"Miller","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/75.4.386_bib83","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Serostim Study Group. Recombinant human growth hormone in patients with HIV-associated wasting: a randomized, placebo-controlled trial","volume":"125","author":"Schambelan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/75.4.386_bib84","first-page":"1","article-title":"Human growth hormone approved for wasting","volume":"254","author":"James","year":"1996","journal-title":"AIDS Treat News"},{"key":"10.4065\/75.4.386_bib85","article-title":"Serono Serostim required on state Medicaid formularies, HCFA says","volume":"61","year":"1999","journal-title":"FDC Reports"},{"key":"10.4065\/75.4.386_bib86","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/apc.1999.13.391","article-title":"Short-term human growth hormone therapy for HIV-associatcd wasting |letter]","volume":"13","author":"Nemechek","year":"1999","journal-title":"AIDS Patient Care STDS"},{"key":"10.4065\/75.4.386_bib87","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0272-2712(18)30451-7","article-title":"Financial implications of malnutrition","volume":"13","author":"Bernstein","year":"1993","journal-title":"Clin Lab Med"},{"key":"10.4065\/75.4.386_bib88","unstructured":"Nemechek PM. Impact of comprehensive medical, nutritional, and psychological care on total body weight and body cell mass in HIV+ men with malnutrition. In: Program and abstracts of the 12th World AIDS Conference; June 28-July 3, 1998; Geneva, Switzerland."},{"key":"10.4065\/75.4.386_bib89","unstructured":"Pierson R, Wang J, Landy H, Breitmeyer J, Kotler D. Clinical relevance of DEXA-ectermined lean body mass in patients with AIDS wasting. In: Program and abstracts of the XI International Conference on AIDS; July 7\u201312.1996; Vancouver, British Columbia. Abstract Mo.B.I392."},{"key":"10.4065\/75.4.386_bib90","unstructured":"Daar ES, LaMarca A, Schambelan M, Gruinfeld C, Mulligan K, Breitmeyer J. Effects of continuous growth hormone therapy on lean body mass (LBM) and AIDS-dcfming events in HlV-associated wasting (HIV-W). In: Program and abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections; January 28-February I. 1996; Washington, DC. Abstract 125."},{"key":"10.4065\/75.4.386_bib91","series-title":"Serostim (somatropin [rDNA origin] for injection) [package insert]","year":"1998"},{"key":"10.4065\/75.4.386_bib92","series-title":"Serono Laboratories I: data on file","year":"1998"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611640354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611640354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:56:02Z","timestamp":1633010162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611640354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S0025619611640354"],"URL":"https:\/\/doi.org\/10.4065\/75.4.386","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}